Evidence mapPaperPMID 41994115Full record

ArticleResearch square2026

Design and Synthesis of Odorranalectin-Derived Peptides for RNA Binding.

Tamara Damjanovic, Predrag Cudic

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tamara DamjanovicFlorida Atlantic University.
Predrag CudicFlorida Atlantic University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small interfering RNA (siRNA) holds significant therapeutic potential for a broad range of diseases, including diseases of the central nervous system, yet its clinical translation remains limited by the lack of efficient and targeted delivery strategies, largely due to poor membrane permeability. To address this challenge, we developed a multifunctional RNA delivery platform by integrating positively charged cell-penetrating peptide sequences into the lectin-mimicking cyclic peptide odorranalectin (OL), which has demonstrated nose-to-brain transport capability. Placement of the cationic sequence at the

Indexed as

bindingCharged cyclic peptidesintranasal deliveryodorranalectinRNA

Identifiers

PMID41994115
PMCPMC13082161

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.